Literature DB >> 26764204

Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.

Shrikant R Mulay1, Jonathan N Eberhard1, Victoria Pfann2, Julian A Marschner1, Murthy N Darisipudi2, Christoph Daniel3, Simone Romoli1, Jyaysi Desai1, Melissa Grigorescu1, Santhosh V Kumar1, Birgit Rathkolb4,5, Eckhard Wolf5, Martin Hrabě de Angelis4,6,7, Tobias Bäuerle8, Barbara Dietel9, Carsten A Wagner10, Kerstin Amann3, Kai-Uwe Eckardt2, Peter S Aronson1, Hans Joachim Anders1, Felix Knauf11,12.   

Abstract

Chronic kidney disease (CKD) research is limited by the lack of convenient inducible models mimicking human CKD and its complications in experimental animals. We demonstrate that a soluble oxalate-rich diet induces stable stages of CKD in male and female C57BL/6 mice. Renal histology is characterized by tubular damage, remnant atubular glomeruli, interstitial inflammation, and fibrosis, with the extent of tissue involvement depending on the duration of oxalate feeding. Expression profiling of markers and magnetic resonance imaging findings established to reflect inflammation and fibrosis parallel the histological changes. Within 3 wk, the mice reproducibly develop normochromic anemia, metabolic acidosis, hyperkalemia, FGF23 activation, hyperphosphatemia, and hyperparathyroidism. In addition, the model is characterized by profound arterial hypertension as well as cardiac fibrosis that persist following the switch to a control diet. Together, this new model of inducible CKD overcomes a number of previous experimental limitations and should serve useful in research related to CKD and its complications.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  CKD-MBD; cardiovascular; hypertension; oxalate; renal failure

Mesh:

Substances:

Year:  2016        PMID: 26764204      PMCID: PMC5504458          DOI: 10.1152/ajprenal.00488.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

Review 1.  US Renal Data System 2013 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Blanche Chavers; David Gilbertson; Charles Herzog; Areef Ishani; Kirsten Johansen; Bertram L Kasiske; Nancy Kutner; Jiannong Liu; Wendy St Peter; Haifeng Guo; Yan Hu; Allyson Kats; Shuling Li; Suying Li; Julia Maloney; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Bryn Thompson; Eric Weinhandl; Hui Xiong; Akeem Yusuf; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frank Daniels; James Ebben; Eric Frazier; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2014-01       Impact factor: 8.860

2.  THE NATURE OF THE "INORGANIC PHOSPHATE" IN VOLUNTARY MUSCLE.

Authors:  C H Fiske; Y Subbarow
Journal:  Science       Date:  1927-04-22       Impact factor: 47.728

3.  Blood Collection from Mice and Hematological Analyses on Mouse Blood.

Authors:  Birgit Rathkolb; Helmut Fuchs; Valérie Gailus-Durner; Bernhard Aigner; Eckhard Wolf; Martin Hrabě de Angelis
Journal:  Curr Protoc Mouse Biol       Date:  2013-06-01

4.  Clinical Chemistry and Other Laboratory Tests on Mouse Plasma or Serum.

Authors:  Birgit Rathkolb; Wolfgang Hans; Cornelia Prehn; Helmut Fuchs; Valérie Gailus-Durner; Bernhard Aigner; Jerzy Adamski; Eckhard Wolf; Martin Hrabě de Angelis
Journal:  Curr Protoc Mouse Biol       Date:  2013-06-01

5.  Policy: NIH to balance sex in cell and animal studies.

Authors:  Janine A Clayton; Francis S Collins
Journal:  Nature       Date:  2014-05-15       Impact factor: 49.962

6.  Experimental folic acid nephropathy.

Authors:  M Fink; M Henry; J D Tange
Journal:  Pathology       Date:  1987-04       Impact factor: 5.306

Review 7.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

8.  Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease.

Authors:  Shrikant R Mulay; Andrew Evan; Hans-Joachim Anders
Journal:  Nephrol Dial Transplant       Date:  2013-10-25       Impact factor: 5.992

Review 9.  Advances in parametric mapping with CMR imaging.

Authors:  Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

10.  Smad7 protects against chronic aristolochic acid nephropathy in mice.

Authors:  Xiao-Yu Dai; Li Zhou; Xiao-Ru Huang; Ping Fu; Hui-Yao Lan
Journal:  Oncotarget       Date:  2015-05-20
View more
  39 in total

1.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

2.  Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.

Authors:  Laura I Neumeier; Robert B Thomson; Martin Reichel; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

3.  Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study.

Authors:  Ruth Lagies; Floris E A Udink Ten Cate; Markus Feldkötter; Bodo B Beck; Narayanswami Sreeram; Bernd Hoppe; Ulrike Herberg
Journal:  Pediatr Nephrol       Date:  2019-08-22       Impact factor: 3.714

4.  Characterization of renal NaCl and oxalate transport in Slc26a6-/- mice.

Authors:  Felix Knauf; Heino Velazquez; Victoria Pfann; Zhirong Jiang; Peter S Aronson
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-14

Review 5.  The gut microbiota and its relationship with chronic kidney disease.

Authors:  Consuelo Plata; Cristino Cruz; Luz G Cervantes; Victoria Ramírez
Journal:  Int Urol Nephrol       Date:  2019-10-01       Impact factor: 2.370

Review 6.  Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity.

Authors:  Orhan Efe; Ashish Verma; Sushrut S Waikar
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 7.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

8.  Halodule pinifolia (Seagrass) attenuated lipopolysaccharide-, carrageenan-, and crystal-induced secretion of pro-inflammatory cytokines: mechanism and chemistry.

Authors:  Sajeli Ahil Begum; Kirti Hira; Pragya Paramita Pal; Samrun Nessa; Onkar P Kulkarni; Jeyapragash Danaraj; Ameer Basha Shaik; Hiroshi Araya; Yoshinori Fujimoto
Journal:  Inflammopharmacology       Date:  2020-09-12       Impact factor: 4.473

9.  Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.

Authors:  Shrikant R Mulay; Jonathan N Eberhard; Jyaysi Desai; Julian A Marschner; Santhosh V R Kumar; Marc Weidenbusch; Melissa Grigorescu; Maciej Lech; Nuru Eltrich; Lisa Müller; Wolfgang Hans; Martin Hrabě de Angelis; Volker Vielhauer; Bernd Hoppe; John Asplin; Nicolai Burzlaff; Martin Herrmann; Andrew Evan; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

10.  Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease.

Authors:  Sarah E Motta; Pedro Henrique Imenez Silva; Arezoo Daryadel; Betül Haykir; Eva Maria Pastor-Arroyo; Carla Bettoni; Nati Hernando; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2020-03-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.